The role of histone lysine methyltransferase NSD3 in cancer

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax domain-containing 3 (NSD3) is increasingly recognized for its amplification and overexpression across diverse cancer types.
• The precise biological functions of NSD3 in the development and progression of cancer remain incompletely elucidated.

Purpose of the Study:

• To consolidate current understanding of the regulatory mechanisms governing NSD3 expression in various cancers.
• To explore the potential of NSD3 as a therapeutic target for precision cancer treatments.

Main Methods:

• Literature review of existing studies on NSD3.
• Analysis of NSD3 amplification and overexpression data in multiple cancer types.
• Synthesis of information on NSD3's role in carcinogenesis.

Main Results:

• NSD3 amplification and overexpression are common features in numerous cancers.
• Evidence suggests NSD3 plays a significant role in cancer development.
• Mechanisms of NSD3 regulation in different cancers are being uncovered.

Conclusions:

• NSD3 is a frequently altered gene in cancer with implications for tumorigenesis.
• Further research into NSD3 regulation is crucial for understanding its role in cancer.
• NSD3 presents a promising druggable target for future targeted cancer therapies.